Search clinical trials for: NKTR-255
Total 2783 results
-
Nektar TherapeuticsCompletedMultiple Myeloma | Non-Hodgkin Lymphoma | Indolent Non-Hodgkin LymphomaUnited States
-
M.D. Anderson Cancer CenterNektar TherapeuticsRecruitingLung CancerUnited States
-
U.S. Army Medical Research and Development CommandUniformed Services University of the Health Sciences; Meiji Seika Pharma Co...No longer availableInfection Due to Resistant OrganismUnited States
-
Nektar TherapeuticsRecruitingNon-Hodgkin Lymphoma | Relapsed/Refractory Diffuse Large B-cell LymphomaUnited States
-
Nektar TherapeuticsCompletedCervical Cancer | Colorectal Cancer | Head and Neck Squamous Cell Carcinoma | Anal Squamous Cell Carcinoma | Cutaneous Squamous Cell CarcinomaUnited States
-
AbelZeta, Inc.Nektar TherapeuticsRecruiting
-
Nektar TherapeuticsCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsCompletedLow Back Pain | Chronic PainUnited States
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Calithera Biosciences, IncNektar TherapeuticsWithdrawnLymphoma, Non-HodgkinUnited States, Canada
-
Nektar TherapeuticsCompletedMalignant Solid TumorUnited States, Belgium
-
Nektar TherapeuticsCompletedLow Back Pain | Chronic PainUnited States
-
Nektar TherapeuticsCompletedAdvanced or Metastatic Solid Tumors in Patients With Hepatic ImpairmentUnited States
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, Germany; Gilead Sciences; Nektar TherapeuticsRecruitingLocally Advanced or Metastatic Urothelial CarcinomaKorea, Republic of, United States, Taiwan, Australia, United Kingdom, France, Greece, Italy, Belgium, Spain, Canada, Denmark, Germany
-
Nektar TherapeuticsCompletedCovid-19 | Coronavirus Disease 2019United States
-
Nektar TherapeuticsCompletedOvarian Cancer | TumorUnited States, Belgium, United Kingdom
-
Nektar TherapeuticsEli Lilly and CompanyCompleted
-
Nektar TherapeuticsEli Lilly and CompanyCompletedSystemic Lupus ErythematosusUnited States
-
Nykode Therapeutics ASANektar Therapeutics; Vaccibody ASCompletedLocally Advanced or Metastatic Solid TumoursGermany
-
Nektar TherapeuticsEli Lilly and CompanyCompletedSystemic Lupus ErythematosusUnited States, Spain, Japan, India, Israel, Korea, Republic of, Taiwan, Australia, Puerto Rico, Argentina, Romania, Canada, Germany, Russian Federation, Mexico, Ukraine, Poland, Czechia, Hungary
-
Nektar TherapeuticsEli Lilly and CompanyTerminatedColitis, UlcerativeAustralia, India, United States, Korea, Republic of, Hungary, United Kingdom, Japan, Argentina, Belgium, Brazil, Canada, China, Czechia, France, Georgia, Israel, Latvia, Poland, Romania, Russian Federation, Slovakia, Ukraine
-
Università Politecnica delle MarcheUnknownInfant, Very Low Birth WeightItaly
-
TakedaTakeda Development Center Americas, Inc.RecruitingThrombotic Thrombocytopenic Purpura (TTP)United States, Spain, Italy, Greece, United Kingdom, Argentina, Poland, Austria
-
Nektar TherapeuticsCompletedOsteoarthritis of the KneeUnited States
-
TakedaShire; Takeda Development Center Americas, Inc.RecruitingThrombotic Thrombocytopenic Purpura (TTP)China, United States, France, Japan, Poland, Germany, Austria, Spain, Italy, Switzerland, United Kingdom
-
Nektar TherapeuticsRecruitingModerate to Severe Atopic DermatitisUnited States, Canada
-
Nektar TherapeuticsRecruiting
-
Baxalta now part of ShireTakeda Development Center Americas, Inc.RecruitingThrombotic Thrombocytopenic Purpura (TTP)United States, Spain, Poland, Italy, Germany, France, Switzerland, Austria, Japan, United Kingdom
-
Nektar TherapeuticsCompletedColorectal Cancer | TumorUnited States
-
Chinese PLA General HospitalTsinghua UniversityUnknownGlioma | Breast Cancer | Pancreatic Cancer | Prostate Cancer | Colon Cancer | Hepatocellular Cancer | Squamous Cell Lung CancerChina
-
Peking University Cancer Hospital & InstituteUnknown
-
Centre Hospitalier Universitaire de NiceCompletedUnrecognized Condition
-
Alkahest, Inc.CompletedEnd-Stage Renal DiseaseUnited States
-
Eisai Inc.Completed
-
Nektar TherapeuticsBristol-Myers SquibbCompletedMelanoma | Renal Cell Carcinoma | Gastric Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Urothelial Carcinoma | HR+/HER2- Breast CancerUnited States, Spain, Canada, France, Italy, Belgium, Poland, United Kingdom
-
Abbott Medical DevicesAbbottCompletedMitral Regurgitation | Mitral Valve RegurgitationNetherlands, United Kingdom, United States, Spain, Israel, Germany, Italy, Switzerland
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; Stanford University; Rockefeller UniversityActive, not recruiting
-
Fred Hutchinson Cancer CenterNektar TherapeuticsRecruitingRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Recurrent Grade 3b Follicular Lymphoma | Refractory Grade 3b Follicular... and other conditionsUnited States
-
Imperial College LondonAstraZeneca; Medical Research Council; National Institute for Health Research...CompletedMenopausal FlushingUnited Kingdom
-
Celyad Oncology SAUnknownAcute Myeloid Leukemia/Myelodysplastic Syndrome | Multiple Myeloma (MM)United States, Belgium
-
Nektar TherapeuticsCompletedBreast Cancer | TumorUnited States, Belgium, United Kingdom
-
Nektar TherapeuticsCompletedAdvanced Cancer | Metastatic Solid TumorsUnited States
-
University of Kansas Medical CenterCompletedGeneral SurgeryUnited States
-
BioCardia, Inc.Not yet recruiting
-
BioMarin PharmaceuticalRecruitingNonalcoholic Fatty Liver Disease | Kidney Stone | HyperoxaluriaUnited States
-
Nektar TherapeuticsTerminatedMelanoma | Sarcoma | Renal Cell Carcinoma | Colorectal Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Merkel Cell CarcinomaUnited States
-
Lawrence RechtNektar TherapeuticsCompletedAnaplastic Astrocytomas | Glioblastomas (GBM) | Anaplastic OligodendrogliomasUnited States